• Tiếng Việt
  • English
  • Sunday, March 08, 2026, 04:59 (GMT+7)

More than 6,000 people signed up for the phase 3 trial of the Nanocovax vaccine

03:53 11/06/2021 - Disease prevention
As of noon on June 7, more than 6,000 people had signed up for the phase 3 trial of Nanocovax's Covid-19 vaccine Nanogen.
Ảnh minh họa

Nanocovax vaccine will start phase 3 trial this week

According to the Military Medical Academy, the number of volunteers is increasing rapidly every hour. In just the past 10 days, more than 5,000 people have registered, bringing the total number of volunteers who want to participate in the phase 3 trial of the Covid-19 vaccine Nanocovax to more than 6,000 people.

In phase 3, Nanocovax vaccine will be tested at many centers in the country with about 13,000 volunteers. In the North, clinical trials were conducted at the Military Medical Academy and Hung Yen, and in the South, the Pasteur Institute in Ho Chi Minh City and Long An participated. In Long An, the number of registered volunteers has not been aggregated because the localities have not submitted it.

It is expected that this week, the Nanocovax vaccine will begin a phase 3 trial, which will be divided into several small phases, with a single injection of 25mcg dose group and a control group of placebo injections.

After the phase 3 trial period for around 2 months, when enough data is available, the Ministry of Health can submit it to the Prime Minister and Deputy Prime Minister for consideration and urgent approval of the Nanocovax vaccine to be widely administered to the people.

The results of the first two-phase trial showed that the Nanocoax vaccine was safe, 100% of the volunteers produced antibodies from tens to hundreds of times, much higher than expected.

The vaccine is also effective against the British and South African variant. The effect with the Indian variant will continue to be studied in phase 3.

Nanocovax vaccine has been developed by Nanogen company since May 2020 based on recombinant protein technology. This is a stable vaccine production technology that has been around for a long time.

Phase 1 trial of Nanocovax vaccine started from December 17th, 2020, and phase 2 has been completed by April 8th.

Currently, Nanogen has received financial support from a domestic bank, the company is preparing materials and lines so that when the vaccine is successful, it will be mass-produced. The maximum capacity of the plant is about 6 million doses/month.

Long Tran

Related News

Read More in This Category

Vietnam's first monkeypox patient discharged

Vietnam's first monkeypox patient discharged

Disease prevention - 14/10/2022

The unnamed patient, treated at the Ho Chi Minh City Hospital for Tropical Diseases, had recovered and her skin injuries have been healed. Her close c...

Vietnam to monitor entrants from monkeypox areas for 21 days

Vietnam to monitor entrants from monkeypox areas for 21 days

Disease prevention - 23/08/2022

An electron microscopic (EM) image shows mature, oval-shaped monkeypox virus particles as well as crescents and spherical particles of immature vi...

Dengue fever kills 9 in HCMC

Dengue fever kills 9 in HCMC

Disease prevention - 21/06/2022

Dengue fever kills 9 in HCMC   Of the patients, 274 were critical, compared to 31 last year, according to the HCMC Center for Disease Contro...

Hai Phong leads in public administration reform index

Hai Phong leads in public administration reform index

Disease prevention - 26/05/2022

The citizen reception area at the People's Committee office of Hai An District in Hai Phong City, March 2020. Photo by VnExpress/Gia Chinh  ...

Vaccination Schedule Vietnam Ministry of Health